Forgot Password?

If you are Corporate user, please
click here
If you have a user ID already and cannot login, contact Customer Support
You can begin the registration process by clicking here

Welcome

Welcome to the Jazz Pharmaceuticals online system for submission of US-based Corporate Giving (CG) and Investigator-Sponsored Trial (IST) support requests. For Non-US Corporate Giving requests, please contact corpgiving@jazzpharma.com .

To submit a request for CG or IST funding, please create an account or log in with your existing account information.

Jazz Corporate Giving Portal

At Jazz Pharmaceuticals, we view our corporate giving as an opportunity for us to help improve patients' lives by filling unmet needs, to demonstrate our commitment to the communities we serve by building powerful collaborations, and to make an impact through meaningful investments in organizations, initiatives and causes that reflect our mission, values and strategic focus. Jazz Pharmaceuticals is committed to supporting programs through corporate grants and sponsorships that benefit patients and the scientific or medical community. These supported programs are healthcare-related and consistent with Jazz Pharmaceuticals' therapeutic areas of focus. We are also committed to being an exemplary corporate citizen and contributing to the wellbeing of the communities in which we live and work.

Jazz Pharmaceuticals accepts unsolicited corporate giving requests on a biannual basis. We will accept requests for 2018 funding during the months of October 2017 and April 2018. Corporate giving applications must be submitted and accepted at least 60 days in advance of the activity date.

For eligibility requirements, please refer to our website at https://www.jazzpharma.com/responsibility/corporate-giving/ .

Funding applications must be received for review at least 60 days in advance of the funded event or activity for consideration. All required documentation must be received before a funding request can be considered.

Required Documentation

  • Cover letter with formal request
  • Event or program description/background information
  • W-9 (year to date)
  • Program Budget
  • Letter of Determination Status/Tax-Exempt Status
  • Form 990
  • List of Board of Directors
  • Written confirmation as to whether any of the organization's officers or principals are HCPs, government officials/employees, or relatives of government officials/employees

Jazz Investigator-Sponsored Trial (IST) Portal

Jazz Pharmaceuticals is committed to improving patient care by developing meaningful products that address unmet medical needs and by supporting externally sponsored research. Jazz welcomes your independent and unsolicited proposals where you as the Investigator, organization or institution (academic, private, or governmental) serves as the Sponsor, and Jazz provides support in the form of funding, study drug, and/or authorization to reference Jazz's NDA or other regulatory submissions (e.g., IND).

Please note that submission of a proposal does not imply or guarantee approval and that support is awarded strictly based on scientific merit and clinical value criteria.

Jazz has a two-stage review process: concept and protocol review. After submitting your concept, our Review Committee will notify you of our decision. If your concept is accepted, Jazz will invite you to submit a full protocol within 90 days of the notification.

Please be prepared to provide the following information at the time of your concept submission:

  • Primary Investigator information and a current CV
  • Study hypothesis, objectives, and endpoints
  • Background & rationale
  • Study design
  • Subject population
  • Statistical analysis plan
  • Publication plan
  • Detailed and itemized budget utilizing the Jazz template
  • Quantity of product requested (if applicable)

For additional information about our IST program, please refer to our IST Handbook.

Visit www.jazzpharma.com for further information about our products and therapeutic areas of interest.

Use and access of this site is subject to the Terms of Use & Privacy Notice .